Results 161 to 170 of about 24,138 (220)

Design of a novel multi-epitope vaccine candidate against Yersinia pestis using advanced immunoinformatics approaches: An in silico study. [PDF]

open access: yesBiochem Biophys Rep
Saadh MJ   +10 more
europepmc   +1 more source

A bacteriophage cocktail targeting <i>Yersinia pestis</i> provides strong post-exposure protection in a rat pneumonic plague model. [PDF]

open access: yesMicrobiol Spectr
Kilgore PB   +10 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Yersinia pestis and plague

Biochemical Society Transactions, 2003
Yersinia pestis is the aetiological agent of plague, a disease of humans that has potentially devastating consequences. Evidence indicates that Y. pestis evolved from Yersinia pseudotuberculosis, an enteric pathogen that normally causes a relatively mild disease. Although Y.
R W, Titball   +3 more
openaire   +2 more sources

Yersinia pestis (plague) vaccines

Expert Opinion on Biological Therapy, 2004
Live attenuated and killed whole cell vaccines against disease caused by Yersinia pestis have been available since the early part of the last century. Although these vaccines indicate the feasibility of protecting against disease, they have a number of shortcomings. The live attenuated vaccine is highly reactogenic and is not licensed for use in humans.
Richard W, Titball, E Diane, Williamson
openaire   +2 more sources

Home - About - Disclaimer - Privacy